Our mission is to enable immediate detection of treatment response in support of precision medicine across cancer therapies and emerging immunotherapies.
Accelerating Drug Discovery
Lodestone’s biomarker monitoring technology provides signals of efficacy to guide the development of emerging immunotherapies during preclinical development.
Learn About Our Current Solutions
Enabling Precision Medicine
Non-invasive, longitudinal, real-time monitoring of signaling factors in the tumor microenvironment will accelerate clinical trials and enable true precision medicine as the new standard of care.
Learn About Our Future Developments